Ga-68 DOTA-Exendin-4 and F-18 exendin-4 are glucagon-like peptide-1 receptor analogues that show high diagnostic accuracy for benign insulinomas, but their lower expression is seen in malignant insulinomas. Here, GLP1R is linked to pancreatic insulinoma.